Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to the newest version of your browser.

Your browser appears to have cookies disabled. For the best experience of Construction News, please enable cookies in your browser.

Welcome to the Construction News site. As we have relaunched, you will have to sign in once now and agree for us to use cookies, so you won't need to log in each time you visit our site.
Learn more

Cambridge Biomedical Campus plans for 75,000 sq m expansion accepted

Cambridge Biomedical Campus has secured planning approval for a 75,000 sq m expansion. 

Joint developers Liberty Property Trust and Countryside were given the go-ahead by Cambridge City Council to start works on the next phase of campus development.

Research and development facilities and new clinical space for Cambridge University Hospitals will be built.

Skanska is currently building the new £165m Papworth Hospital for patients requiring lung and heart treatment on the campus, though the project was originally meant to be completed in late 2015.

Construction work on the hospital was meant to start in late 2012, but the Treasury only approved the project in May 2014. Works are expected to be finished by 2018.

Works on campus are also currently under way to build a new global headquarters for clinical company AstraZeneca.

Kier also scooped a £79m contract with the University of Cambridge to build a research facility on the campus in February.

The six-storey 18,000 sq m ‘Project Capella’ research facility includes the university’s stem cell research centre.

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.